Skip to main content
Equibles
PDSB logo

PDSB · PDS Biotechnology Corp · Webcasts, Transcripts & Audio

Track PDSB — free

Use PDSB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PDSB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.75 +0.04 (+6.00%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$44.61M
Shares
55.97M
Volume · Oct 2 3.66M Avg daily vol (3M) 21.61M

PDS Biotechnology Corp Webcasts

Earnings calls, investor updates, investor days and conferences for PDS Biotechnology Corp (PDSB), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q1
2026-05-13
PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Transcript
Confident tone PDS01ADC in prostate and colorectal cancer PDS0101 for HPV16-positive head and neck cancer Manufacturing and CMC readiness for BLA
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Transcript
Confident tone VERSATILE-002 Phase II data VERSATILE-003 Phase III protocol amendment Unmet need in HPV16-positive head and neck cancer
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
PDS Biotechnology Corp (PDSB) Q3 2025 Earnings Call Transcript
Confident tone VERSATILE-003 Protocol Amendment VERSATILE-002 Final Data PDS0101 Lead Asset
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
PDS Biotechnology Corp (PDSB) Q2 2025 Earnings Call Transcript
Confident tone HPV16-Positive Head and Neck Cancer Opportunity VERSATILE-003 Phase III Trial VERSATILE-002 Phase II Data
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Transcript
Confident tone VERSATILE 003 Phase 3 trial initiation ASCO 2025 data presentations Keynote 689 / standard of care impact
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Transcript
Confident tone HPV-positive head and neck cancer opportunity VERSATILE-003 Phase 3 trial design update VERSATILE-002 updated efficacy and durability data
Diluted EPS
$-0.29
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
PDS Biotechnology Corp (PDSB) Q4 2023 Earnings Call Transcript
Confident tone Triple combination strategy in head and neck cancer Drug platform technology and mechanism of action Shift away from VERSATILE-003
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
PDS Biotechnology Corp (PDSB) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.35
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
PDS Biotechnology Corp (PDSB) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.37
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
PDS Biotechnology Corp (PDSB) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
PDS Biotechnology Corp (PDSB) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
PDS Biotechnology Corp (PDSB) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.26
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
PDS Biotechnology Corp (PDSB) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
PDS Biotechnology Corp (PDSB) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
PDS Biotechnology Corp (PDSB) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
PDS Biotechnology Corp (PDSB) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.24
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
PDS Biotechnology Corp (PDSB) Q2 2021 Earnings Call Transcript
Diluted EPS
$-0.03
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
PDS Biotechnology Corp (PDSB) Q1 2021 Earnings Call Transcript
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-18
PDS Biotechnology Corp (PDSB) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
PDS Biotechnology Corp (PDSB) Q3 2020 Earnings Call Transcript
Diluted EPS
$-0.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
PDS Biotechnology Corp (PDSB) Q2 2020 Earnings Call Transcript
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
PDS Biotechnology Corp (PDSB) Q1 2020 Earnings Call Transcript
Diluted EPS
$-0.39
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 webcasts
Key facts CIK 1472091 CUSIP 70465T107 13F (30d) 1 filings 1 filers Visit website Investor relations